Diagnostic anti-trefoil factor 3 (TFF3) antibodies (anti-trefoil factor 3, anti-TFF3) and diagnostic hapten-carrier conjugates BSA-trefoil factor 3 (TFF3), OVA-trefoil factor 3 (TFF3), KLH-trefoil factor 3 (TFF3) antigens for Cancer TFF3 detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Genemedi produces core diagnostic ingredients for test of Cancer (gastric cancer) and related syndrome. GeneMedi offers paired anti-trefoil factor 3 (TFF3) antibodies (monoclonal antibody, mab) and trefoil factor 3 (TFF3 antigens (Carrier-coupled antigen, immunogen, hapten-carrier conjugates, BSA-conjugated, OVA-conjugated, KLH-conjugated) for Cancer (gastric cancer) rapid test kit of trefoil factor 3 (TFF3) testing in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. The carrier-coupled antigens of small molecules can act as immunogens.The trefoil factor (TFF) family consists of three thermostable and protease-resistant proteins, TFF1, TFF2, and TFF3. These proteins are thought to play a pivotal role in mucosal protection against damage. Their oncogenic potential has also been reported to be associated with cell proliferation, apoptosis, migration, and invasion and angiogenesis. The expression of these peptides in the gastrointestinal tract occurs in a tissue- and cell-specific manner. TFF1 and TFF2 are predominantly expressed in gastric mucosa, while TFF3 is expressed in goblet cells of the intestine and also at lower levels in other organs such as the breast, salivary gland, respiratory tract, and hypothalamus. Recently, serum levels of TFFs in cancer patients, including those with gastric cancer, have been reported to be increased and therefore could be useful biomarkers for screening.